Financial Data and Key Metrics Changes - For the full year 2025, the company generated total revenue of $475.6 million, an increase from $463.3 million in 2024, primarily driven by growth in cloud mining solutions, mining equipment sales, and hosting services [17][18] - The company recorded a net loss of $57.4 million in 2025, compared to a net income of $54 million in 2024, attributed to a larger non-cash impairment loss on mining equipment and increased unrealized fair value losses [24][25] - Adjusted EBITDA for the full year was $8.3 million, indicating positive operational performance despite the net loss [25] Business Line Data and Key Metrics Changes - Cloud mining business generated a record $350.6 million in 2025, up over 29% from $271 million in 2024, accounting for nearly 74% of total revenue [5][18] - Self-mining revenue decreased to $63.1 million in 2025 from $157.5 million in 2024, representing about 13% of total revenue compared to 34% in 2024 [19] - Mining equipment sales increased by 76.4% year-over-year to $53.7 million, driven by strong demand for the S21 series [23] Market Data and Key Metrics Changes - The company ended 2025 with 1,778 Bitcoins, an increase from 1,720 Bitcoins at the end of 2024, and continued to build its Bitcoin treasury into 2026, reaching 1,830 Bitcoins by February 28, 2026 [12][26] - The average cash cost to mine one Bitcoin was $77,573 in 2025, reflecting a blended cost structure across self-mining operations [20] Company Strategy and Development Direction - The company focuses on a hybrid model of cloud mining and self-mining, aiming to balance upside potential and operational resilience [9][10] - Strategic priorities for 2026 include scaling cloud mining, expanding managed capacity, improving reliability through the Aladdin system, optimizing capital allocation, and building the Bitcoin treasury [16][27] - The company aims to evaluate opportunities for expanding owned capacity, particularly in North America and the Middle East, while maintaining disciplined capital allocation [26][27] Management's Comments on Operating Environment and Future Outlook - The cryptocurrency industry faced challenges in 2025, particularly for mining enterprises, due to Bitcoin price volatility, which created cash flow pressures for many participants [4][5] - The management believes that the current market environment presents opportunities for growth, particularly in acquiring infrastructure and expanding customer bases during market dips [15][16] - The company maintains a conservative debt profile and liquidity management strategy to navigate through market cycles [12][27] Other Important Information - The company successfully onboarded additional suppliers and diversified its hash rate supply to mitigate risks associated with supplier concentration [7] - The net dollar retention rate was 100% in 2025, indicating strong customer loyalty despite market fluctuations [11] Q&A Session Summary Question: Why are some customers willing to pay a premium for cloud mining services instead of buying Bitcoin directly? - Customers benefit from dollar cost averaging and cost visibility, allowing systematic exposure to Bitcoin over time [27][28] - Financial leverage through installment payments enables customers to invest more in hash rate rather than upfront Bitcoin purchases [28] - Cloud mining offers dynamic output based on network conditions, providing potential for higher returns compared to direct purchases [28][29] - Institutional customers prefer cloud mining for operational revenue recognition and compliance with stringent regulations [29][30]

Financial Data and Key Metrics Changes - As of December 31, 2025, cash equivalents, restricted cash, and fixed-term deposits amounted to $211 million, a decrease of $53 million from $264 million as of December 31, 2024, primarily due to cash payments and operational expenses [20][21] - The company reported a consolidated net loss attributable to shareholders for the twelve months ended December 31, 2025, with specific figures available in the press release [21] Business Line Data and Key Metrics Changes - The allogeneic CAR-T candidate lasme-cel achieved a 100% overall response rate in the target phase 2 population, converting all patients to transplant-eligible candidates [6][13] - The dual CAR-T candidate eti-cel demonstrated an 88% overall response rate and a 63% complete response rate in heavily pre-treated patients [9][16] Market Data and Key Metrics Changes - Cellectis is advancing its pivotal phase 2 trial for lasme-cel, with site openings in North America and Europe expected to continue into 2026 [8] - The company is also collaborating with partners like Servier and Allogene, with key milestones anticipated in 2026 [19] Company Strategy and Development Direction - Cellectis aims to transform into a late-stage development organization, focusing on delivering clinical results for patients with no therapeutic solutions [4][11] - The company is committed to internalizing its manufacturing capabilities, which has shown improved efficacy compared to external manufacturing [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's financial position to fund operations into the second half of 2027, allowing for continued development of lasme-cel and eti-cel [18] - The management highlighted the importance of their allogeneic CAR-T products in addressing unmet medical needs in oncology, particularly for patients with aggressive diseases [4][6] Other Important Information - The anticipated BLA submission for lasme-cel is planned for the second half of 2028, while eti-cel is expected to progress to pivotal phase 2 in 2027 with a BLA submission in H2 2029 [16] - The company is actively engaging in partnerships to enhance its gene editing platform and expand its product offerings [10][11] Q&A Session Summary Question: Update on lasme-cel and BALLI-01 enrollment - Management confirmed that recruitment is on track and expects to complete data analysis by the end of the year for the first 40 patients [24] Question: Expectations for dose optimization in the pivotal study - Management indicated that they anticipate being able to differentiate between the two dose levels of alemtuzumab based on efficacy and safety [25] Question: Details on Servier arbitration and its impact - The arbitration ruling allowed Cellectis to regain rights to UCART19, while remaining eligible for milestones related to cema-cel [30] Question: Importance of alemtuzumab in lymphodepletion - Management emphasized that alemtuzumab is critical for optimizing lymphodepletion and achieving better patient outcomes [33] Question: Update on esiCell and patient follow-up - Management provided a top-line update indicating strong complete remission rates and plans for further data sharing by the end of the year [37] Question: Application of lymphodepletion in outpatient settings - Management noted that regulatory requirements currently necessitate inpatient delivery, but there is potential for future outpatient use [58] Question: AstraZeneca partnership updates - Management expressed satisfaction with the collaboration but indicated that updates would be limited at AstraZeneca's request due to competitive considerations [60]

Financial Data and Key Metrics Changes - The company reported full year 2025 revenues of EUR 1,917 million, a decrease of 1.5% year-over-year on a reported basis, but an increase of 1.1% on an organic basis [10] - Gross margin improved by 90 basis points to 67.5%, primarily driven by a shift in channel mix, with Direct-to-Consumer (DTC) sales reaching 82% of branded revenues compared to 78% the previous year [11] - Adjusted EBIT was EUR 163 million, which included EUR 10 million in provisions related to losses on trade receivables [10][11] - The company achieved a profit of EUR 109 million, up 20% from EUR 91 million the previous year [11][15] - The effective tax rate decreased to 22% from 30% due to non-taxable income related to the remeasurement of put option liabilities [15] Business Line Data and Key Metrics Changes - The Zegna segment generated an adjusted EBIT of EUR 197 million with a margin of 14.4%, up from 13.9% the previous year [13] - The Thom Browne segment was significantly impacted by a reduction in revenues, achieving only EUR 1 million in adjusted EBIT [14] - The Tom Ford Fashion segment reported a loss of EUR 16 million in adjusted EBIT for the year, with EUR 5 million in provisions related to Saks Global [14] Market Data and Key Metrics Changes - The Middle East region represents a mid-high single-digit share of the company's total revenues, with all stores in the area currently open and operating [18] - The company noted that the Americas and Europe remain resilient despite the conflict in the Middle East, with good growth expected [26] Company Strategy and Development Direction - The company is focusing on enhancing its brand presence through cultural initiatives, such as sponsoring the Italian Pavilion at the Venice Biennale [8] - Future plans include the launch of new collections and collaborations, such as the Thom Browne sneaker with ASICS, aimed at attracting new customers [5][6] - The company is committed to a long-term vision, emphasizing the importance of brand heritage and customer experience [6][9] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the current operating environment, noting slight improvements in DTC trends and performance in various regions, particularly in the Americas and Europe [25][26] - The company remains cautious about the Chinese market, expecting a flattish performance for the year despite some signs of improvement [25][26] - Management acknowledged the uncertainty in the global economic outlook due to geopolitical factors, particularly in the Middle East [19] Other Important Information - The company plans to increase capital expenditures (CapEx) to approximately 7% of revenues in 2026, primarily for the new shoe factory in Parma [16] - Trade working capital improved to EUR 408 million, representing 21.3% of revenues, down from 23.6% the previous year [17] Q&A Session Summary Question: Update on top-line momentum and regional trends - Management noted that the year has started well, with trends slightly better than Q4 2025 in DTC, despite uncertainties from the Middle East conflict [25][26] Question: Zegna segment EBIT margin expectations - Management indicated that the Zegna segment's EBIT margin could improve, with a focus on long-term profitability rather than short-term results [28] Question: Impact of foreign exchange on profitability - Management acknowledged a potential headwind of around 2 points from currency fluctuations affecting profitability [29] Question: Changes in consumer behavior and spending - Management reported no significant changes in consumer behavior outside the Middle East, where traffic has decreased [36] Question: Profitability improvements for Tom Ford and Thom Browne - Management expects profitability for both brands to improve in 2026, with Thom Browne aiming for a return to reasonable profitability [101]

Financial Data and Key Metrics Changes - XPeng's total revenues for Q4 2025 were RMB 22.25 billion, an increase of 38.2% year-over-year and 9.2% quarter-over-quarter [32] - Vehicle sales revenue was RMB 19.07 billion, up 30% year-over-year and 5.6% quarter-over-quarter, primarily due to higher deliveries [32] - Gross margin for Q4 2025 was 21.3%, compared to 14.4% in Q4 2024 and 20.1% in Q3 2025 [33] - Net profit for Q4 2025 was RMB 0.38 billion, marking the first positive net profit for a single quarter [36] Business Line Data and Key Metrics Changes - Annual delivery reached 42,945 units, a 126% increase year-over-year [5] - Revenues from services and others were RMB 3.18 billion, representing a 121.9% year-over-year increase [33] - Vehicle margin for Q4 2025 was 13%, up from 10% in Q4 2024 [34] Market Data and Key Metrics Changes - Overseas deliveries nearly doubled to 45,000 units, contributing over 15% of total revenue [5] - The company aims to double overseas deliveries in 2026, targeting international business to contribute over 20% of total revenue [13] Company Strategy and Development Direction - XPeng plans to launch four new models in 2026, expanding into both large and compact vehicles [11] - The company is focusing on enhancing its global market share and expanding its AI vehicle offerings [12] - XPeng's strategy includes significant investment in R&D, with CNY 9.5 billion allocated in 2025, including CNY 4.5 billion for AI [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving significant growth in the physical AI market, which is expected to surpass the automotive industry in the next 5-10 years [26] - The company anticipates that the VLA 2.0 will enhance user retention and conversion rates, with expectations of higher sales volume [44] - Management highlighted the importance of addressing safety issues and weaknesses in their technology before global deployment [46] Other Important Information - XPeng's cash position as of December 31, 2025, was RMB 47.66 billion, providing robust financial support for ongoing investments [36] - The company has begun construction of a humanoid robot mass production base in Guangzhou, targeting over 1,000 units per month by the end of 2026 [25] Q&A Session Summary Question: What type of major upgrade should we expect for XPeng's VLA 2.0 in the coming months? - Management indicated that they expect at least one major version of OTA each quarter, with significant improvements in autonomous driving capabilities [40][41] Question: What is the deployment roadmap for XPeng Ultra model and VLA 2.0 in the overseas market? - Management confirmed that VLA 2.0 testing is underway, with plans for gradual rollout in international markets by the end of the year [48][50] Question: What are the key markets for achieving 100% volume growth overseas this year? - Europe and Southeast Asia were identified as key markets, with local production efforts underway to support growth [67][70] Question: What is the current progress of Robotaxi testing? - Management stated that fully autonomous driving capability is expected to be achieved in 1-3 years, with ongoing testing and regulatory compliance efforts [78]

Financial Data and Key Metrics Changes - As of December 31, 2025, Cellectis reported cash equivalents, restricted cash, and fixed-term deposits amounting to $211 million, a decrease of $53 million from $264 million as of December 31, 2024, primarily due to cash payments and operational expenses [19][20] - The company managed its cash with discipline, focusing on the development of lasme-cel and eti-cel, and believes its current cash position is sufficient to fund operations into the second half of 2027 [18][19] Business Line Data and Key Metrics Changes - Lasme-cel achieved a 100% overall response rate in the target phase 2 population, with 80% of patients achieving minimal residual disease (MRD) negative status [5][12] - Eti-cel demonstrated an 88% overall response rate and a 63% complete response rate in heavily pre-treated patients during phase 1 trials [8][16] Market Data and Key Metrics Changes - Cellectis is advancing its pivotal phase 2 trial for lasme-cel, with site openings in North America and Europe expected to continue into 2026 [7][12] - The company is also investigating eti-cel's potential impact with low-dose interleukin-2 support to enhance CAR-T efficacy without increasing toxicity [8][16] Company Strategy and Development Direction - Cellectis aims to transform into a late-stage development organization, with 2026 expected to be a year of significant milestones and data readouts [10][17] - The company is focused on delivering clinical results for patients with no therapeutic solutions, emphasizing the importance of its allogeneic CAR-T approach [4][5] Management's Comments on Operating Environment and Future Outlook - Management highlighted the challenges faced by biotechnology companies in recent years but emphasized Cellectis's commitment to advancing its clinical programs [4][5] - The management expressed confidence in the potential of lasme-cel and eti-cel to provide significant therapeutic options for patients with difficult-to-treat cancers [6][8] Other Important Information - Cellectis's gene editing platform is becoming the backbone of a broader allogeneic CAR-T ecosystem, with partnerships with Servier and Iovance advancing their respective programs [9][10] - The company anticipates presenting full phase 1 data for eti-cel later this year and expects to submit a Biologics License Application (BLA) for lasme-cel in the second half of 2028 [17][19] Q&A Session Summary Question: Update on lasme-cel and BALLI-01 enrollment - Management confirmed that recruitment is on track and expects to complete data analysis by the end of the year for the first 40 patients [23][24] Question: Expectations for dose optimization in the pivotal study - Management indicated that they have a strong analysis plan to differentiate between the two alemtuzumab dose levels, focusing on efficacy and safety [25][26] Question: Details on Servier arbitration and its impact - Management clarified that the arbitration ruling allows Cellectis to develop UCART19 independently while remaining eligible for milestones related to cema-cel [28][30] Question: Safety of CD52 preconditioning - Management emphasized the importance of alemtuzumab in optimizing lymphodepletion and achieving better outcomes [32][33] Question: Update on esiCell and patient follow-up - Management provided a top-line update on esiCell, indicating strong complete remission rates and plans for further data on IL-2 cohorts [35][36] Question: Competitive landscape regarding CD19 therapies - Management noted that their focus is on CD22, differentiating their product from others targeting CD19, and emphasized the need for alternative therapies for patients [41][42] Question: Expectations for EHA updates - Management indicated that they will present an updated dataset at EHA, including additional patients and insights on optimal lymphodepletion [50][52] Question: Outpatient setting for lymphodepletion procedures - Management stated that regulatory requirements currently necessitate inpatient delivery, but there is potential for outpatient use in the future [56][57] Question: AstraZeneca partnership updates - Management expressed satisfaction with the collaboration and indicated that updates will be provided when appropriate [58][60]

Financial Data and Key Metrics Changes - In Q4, the company returned to positive net sales growth with a reported increase of 2.2% and approximately 1% on a constant currency basis [3][4] - Gross margin improved to 60.3%, a 10-basis point increase from the previous year, attributed to regional mix and effective tariff mitigations [4][31] - Adjusted EBITDA margin was 20.3% for Q4, maintaining a strong performance while investing in new store openings [32] Business Line Data and Key Metrics Changes - The direct-to-consumer (D2C) business saw strong growth, with D2C e-commerce up 12% and D2C blended sales up 5.2% [12] - Non-travel categories grew by 6.7% year-over-year, now representing 37.6% of total sales [13] - Travel sales experienced a slight decrease of 2.2% compared to the previous year, but showed sequential improvement from -5.3% [14] Market Data and Key Metrics Changes - Asia showed significant improvement with a 5.1% growth on a constant currency basis in Q4, driven by strong performances in China, Korea, India, and Japan [8][9] - North America remained challenging but showed sequential improvements, particularly in the U.S. and Canada [9] - Europe experienced steady growth at 1% for both quarters, with D2C retail up 4.4% and e-commerce up over 9% [9] Company Strategy and Development Direction - The company plans to focus on amplifying brand awareness, enhancing digital capabilities, and expanding into lifestyle bags and accessories [15][18] - Marketing spend is expected to increase to 6.5% of net sales in 2026 to support strategic priorities [40] - The company is preparing for a dual listing in the U.S. to enhance shareholder value [41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term growth driven by travel demand and strategic execution [38] - The ongoing conflict in the Middle East is expected to impact Q1 sales, with a forecast of flat growth on a constant currency basis [39] - The company remains focused on maintaining strong gross margins despite external uncertainties [39] Other Important Information - The company generated strong adjusted free cash flow of $246 million for the year, with a healthy balance sheet showing a net debt position of approximately $1.1 billion [35] - The company received recognition for sustainability efforts, ranking 74th in Time's World's Best Companies in Sustainable Growth for 2025 and 2026 [25] Q&A Session Summary Question: Performance by market and resilience trends - Management noted sequential improvement across all business areas, with specific growth in Japan, Korea, and China, while the Middle East faced challenges [47][48] Question: Cost pressures due to Middle East conflicts - Management acknowledged potential short-term impacts on shipping and raw material costs but emphasized their ability to manage inventory and maintain margins [49][50] Question: Margin expectations for Q1 and store expansion plans - Management indicated that gross margins are expected to remain strong, with store expansions focused on Asia and Europe, particularly for TUMI [55][56] Question: Revenue trends in North America and wholesale customer sentiment - Management observed that wholesale customers in North America are buying cautiously, with a mixed trend for TUMI and improving performance for other brands [62]

Financial Data and Key Metrics Changes - In Q4, the company returned to positive net sales growth with a reported increase of 2.2% and approximately 1% on a constant currency basis [3][4] - Gross margin improved to 60.3%, a 10 basis point increase from the previous year, attributed to regional mix and brand strength [4][31] - Adjusted EBITDA margin was 20.3% for Q4, maintaining a strong performance while investing in new store openings [32][34] - Adjusted net income for Q4 was $106 million, down from $116 million in the prior year [32] Business Line Data and Key Metrics Changes - The direct-to-consumer (D2C) business saw strong growth, with D2C e-commerce up 12% and D2C blended sales up 5.2% [12] - Non-travel categories grew by 6.7% year-over-year, now representing 37.6% of total sales [13] - Travel category sales decreased by 2.2% compared to the prior year but showed sequential improvement from a negative 5.3% [14] Market Data and Key Metrics Changes - Asia experienced a significant recovery with 5.1% growth on a constant currency basis in Q4, driven by strong performance in China, Korea, India, and Japan [8][9] - North America showed sequential improvement, although still facing challenges from prior year comparisons [9] - Europe maintained steady growth at 1% for both quarters, with strong D2C performance particularly in Q4 [9] Company Strategy and Development Direction - The company plans to focus on four strategic pillars: amplifying brand awareness, winning in digital, seizing opportunities in lifestyle bags, and enhancing product development [15][17] - Marketing spend is expected to increase to 6.5% of net sales in 2026 to support these strategic priorities [18][40] - The company is preparing for a dual listing in the U.S. to enhance shareholder value [29][41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term growth driven by travel demand and strategic execution [38] - The ongoing conflict in the Middle East is expected to impact Q1 sales, with a forecast of flat growth on a constant currency basis [38][39] - The company aims to maintain strong gross margins despite uncertainties in the market [39] Other Important Information - The company generated strong adjusted free cash flow of $246 million for the year, with $170 million in Q4 [35] - The balance sheet remains healthy with a net debt position of approximately $1.1 billion [35] - The company received recognition for sustainability efforts, ranking 74th in Time's World's Best Companies in Sustainable Growth [25] Q&A Session Summary Question: Performance by market and resilience trends - Management noted sequential improvement across all business areas, with specific impacts in the Middle East and resilience in Japan, Korea, and China [47][48] Question: Cost pressures from Middle East conflicts - Management acknowledged early signs of cost impacts, particularly in shipping and raw materials, but emphasized their ability to manage margins effectively [49][50] Question: Margin expectations for Q1 and store expansion plans - Margins are expected to remain stable in Q1, with store expansions focused on Asia and Europe, particularly for TUMI [54][56] Question: Revenue trends in North America and wholesale customer sentiment - North America is experiencing a mixed trend, with sell-through strong but wholesale customers remaining cautious [62] Question: Shareholder return expectations post dual listing - The company plans to maintain a dividend payout ratio of around 45% of adjusted net income and will evaluate share buybacks after the dual listing [63][64]

Financial Data and Key Metrics Changes - In Q4 2025, the company reported a net sales increase of 2.2% on a reported basis and approximately 1% on a constant currency basis, marking a return to positive growth [3][4] - Gross margin improved to 60.3%, a 10 basis point increase from the previous year, attributed to regional mix and effective tariff mitigation [4][30] - Adjusted EBITDA margin for Q4 was 20.3%, maintaining strong performance while investing in new store openings [31] Business Line Data and Key Metrics Changes - The direct-to-consumer (D2C) business saw significant growth, with D2C e-commerce up 12% and D2C blended sales up 5.2% [11] - The non-travel category grew by 6.7% year-over-year, now representing 37.6% of total sales [12] - Travel sales experienced a slight decrease of 2.2% compared to the previous year, but showed sequential improvement from a decline of 5.3% [13] Market Data and Key Metrics Changes - The Asia region showed a strong recovery with 5.1% growth on a constant currency basis in Q4, driven by improvements in China, Korea, India, and Japan [7][8] - North America experienced sequential improvements, although still facing challenges from prior year comparisons [8] - Europe maintained steady growth at 1% for both quarters, with strong D2C performance particularly in Q4 [8] Company Strategy and Development Direction - The company plans to focus on four strategic pillars: amplifying brand awareness, winning in digital, seizing opportunities in lifestyle bags, and enhancing product development [14][15] - Increased marketing spend is planned, targeting 6.5% of net sales in 2026 to support brand awareness and long-term growth [16][40] - The company is preparing for a potential dual listing in the U.S. to enhance shareholder value [28][42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term growth driven by travel demand and strategic execution, despite uncertainties from geopolitical conflicts [38][40] - The company anticipates Q1 2026 net sales to be flat on a constant currency basis due to the impact of the Middle East conflict [38] - Management highlighted the importance of maintaining strong gross margins and effective supplier relationships to navigate cost pressures [30][49] Other Important Information - The company generated strong adjusted free cash flow of $246 million for the year, with a healthy balance sheet showing a net debt position of approximately $1.1 billion [35] - The company received recognition for sustainability efforts, ranking 74th in Time's World's Best Companies in Sustainable Growth for 2025 and 2026 [23][24] Q&A Session Summary Question: Performance by market and resilience trends - Management noted sequential improvement across all business areas, with specific impacts in the Middle East and resilience in Japan, Korea, and China [47][48] Question: Cost pressures from Middle East conflicts - Management acknowledged early signs of cost impacts, particularly in shipping and raw materials, but emphasized their ability to manage margins effectively [49][50] Question: Margin expectations for Q1 and store expansion plans - Margins are expected to remain stable in Q1, with store expansions focused on Asia and Europe, particularly for TUMI [54][56] Question: Revenue trends in North America and wholesale customer sentiment - North America showed improving trends, although wholesale customers remain cautious in their purchasing [60][62] Question: Shareholder return expectations post dual listing - The company plans to maintain a dividend payout ratio of around 45% of adjusted net income and will evaluate share buybacks after the dual listing [63][64]

Financial Data and Key Metrics Changes - Revenue increased by 8% year-over-year, driven by yield and volume strength across nearly all package services [6] - Adjusted operating income grew by 7% year-over-year, with a 16% increase in adjusted EPS [25] - Adjusted EPS outlook for FY 2026 raised to $19.30-$20.10 per diluted share [8][29] Business Line Data and Key Metrics Changes - FedEx Express (FEC) revenue grew by 10%, with adjusted operating margin expanding by 50 basis points, marking the sixth consecutive quarter of margin expansion [7] - FedEx Freight revenue declined by 5%, pressured by lower shipments, but revenue per shipment increased by 1% [17][19] - International priority and economy freight revenue grew by 14%, supported by the Tricolor strategy [16] Market Data and Key Metrics Changes - U.S. domestic package yield increased by 5%, while international export package yield grew by 6% [19] - International export volumes increased by 2% year-over-year for the first time in fiscal year 2026 [18] - The company reduced trans-Pacific outbound capacity by approximately 15% and 25% during the quarter [10] Company Strategy and Development Direction - The company is focused on growing in high-margin verticals, transforming its network, and leveraging data and technology for efficiency gains [5] - Plans to spin off FedEx Freight on June 1, 2026, are on track, expected to unlock long-term value for stockholders [6][37] - The introduction of new technologies, such as the Dun & Bradstreet and FedEx Dataworks Retail Momentum Index, aims to enhance service and operational efficiency [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of consolidated Q3 results and updated assumptions for Q4, expecting continued revenue growth [8] - The company is closely monitoring the situation in the Middle East, emphasizing the safety of team members while managing network adjustments [41] - Management acknowledged challenges in the LTL market but remains optimistic about future growth as the market recovers [18] Other Important Information - The company expects $2 billion in cumulative savings from Network 2.0 and associated initiatives by the end of 2027 [9] - The company is committed to maintaining disciplined capital allocation, with FY 2026 CapEx expected to be no more than $4.1 billion [36] Q&A Session Summary Question: Impact of the Iran conflict on operations - Management is monitoring the situation closely and has adjusted the network to accommodate the conflict, with minimal expected impact on overall revenue [41][42] Question: Outlook for the LTL business - Management noted that the LTL industry is experiencing broader market softness, with increased separation costs expected to continue [47] Question: Year-over-year headwinds for Q4 - Management highlighted a $500 million headwind due to variable compensation, LTL business challenges, and MD-11 impacts [54] Question: Sustainability of volume and yield growth - Management acknowledged the current growth as an anomaly but expressed confidence in maintaining momentum into Q4 [59][60] Question: Cost dynamics and future expectations - Management emphasized ongoing cost containment efforts and the potential for further savings as the company continues to implement structural cost-out initiatives [85]

Financial Data and Key Metrics Changes - Revenue increased by 8% year-over-year, driven by yield and volume strength across nearly all package services [4] - Adjusted operating income rose by 7% year-over-year, with adjusted EPS growth of 16%, including a one-time benefit of $0.41 due to a favorable effective tax rate [22][25] - The company raised its FY 2026 adjusted earnings outlook to $19.30-$20.10 per diluted share [6][25] Business Line Data and Key Metrics Changes - FedEx Express (FEC) revenue grew by 10%, with adjusted operating margin expanding by 50 basis points, marking the sixth consecutive quarter of margin expansion [5] - FedEx Freight revenue declined by 5%, pressured by lower shipments, but revenue per shipment increased by 1% due to higher weight per shipment [15][17] - International export package revenue grew by 8%, with significant contributions from Europe and the Asia to Europe lane [14] Market Data and Key Metrics Changes - The company experienced a 14% growth in international priority and economy freight revenue, supported by its Tricolor strategy [14] - U.S. domestic package yield increased by 5%, driven by strength across all services [17] - International export volumes turned positive for the first time in fiscal year 2026, up 2% year-over-year [15] Company Strategy and Development Direction - The company is focused on growing in high-margin verticals, transforming its network, and leveraging data and technology for efficiency gains [4][12] - Plans to spin off FedEx Freight on June 1, 2026, are on track, expected to unlock long-term value for stockholders [4][34] - The transformation to one integrated intelligent network is underway, with 35% of eligible volume expected to flow through optimized facilities by the end of the month [6][7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of consolidated Q3 results and updated assumptions for Q4, expecting continued revenue quality and growth [6][20] - The company is closely monitoring the situation in the Middle East, emphasizing the safety of team members while managing network adjustments [38] - Management acknowledged the challenges posed by global trade policy changes and LTL industry trends but remains focused on revenue quality and operational efficiency [5][22] Other Important Information - The company introduced new digital tracking and returns offerings, enhancing customer experience and operational efficiency [19] - A strategic collaboration with Dun & Bradstreet aims to launch a Retail Momentum Index to provide insights into U.S. retail supply and demand [10] - The company is implementing autonomous robotic systems to improve operational efficiency in package unloading [11] Q&A Session Summary Question: Impact of the Iran conflict on operations - Management stated that the situation is being monitored closely, with network adjustments made to accommodate the conflict, and the broader global demand is expected to continue into Q4 [37][39] Question: Outlook for the LTL business and investments - FedEx Freight's CFO discussed ongoing investments related to the spin-off and the need to improve yield growth, with a focus on enhancing customer experience and pricing discipline [41][43] Question: Sustainability of current volume and yield growth - Management acknowledged the current growth as an anomaly but expressed confidence in maintaining momentum, targeting 4% revenue growth while ensuring revenue quality [55][57]